Lack of appropriate testing remains a barrier for patients eligible for targeted treatment
Invasion of the lumbar spine and iliac vein made resection risky
Dysphagia and SUVmax are predictive, but other suspected factors are not
Research indicates strong rationale for expanding trial eligibility criteria
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Fine-tuning radiation for recurrent cancers
A well-prepared team meets the distinctive needs of patients at hereditary high risk
Early interventions, improved screening access and tailored support services can help patients navigate cancer care
A newer modality for select patients has shown positive outcomes to date
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Why urologic oncologists favor the technique for select patients
Advertisement
Advertisement